Christopher F. Wyatt - 28 Jan 2022 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP & Controller
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
28 Jan 2022
Transactions value $
$0
Form type
4
Filing time
01 Feb 2022, 18:39:09 UTC
Previous filing
09 Nov 2021
Next filing
23 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Award $0 +5.55K $0.00 5.55K 28 Jan 2022 Common Stock 5.55K $236.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.